Role of the Nav1.7 R1150W amino acid change in susceptibility to symptomatic knee osteoarthritis and multiple regional pain.
Valdes
Ana M
AM
St. Thomas' Hospital, King's College London, UK. ana.valdes@kcl.ac.uk
Arden
Nigel K
NK
Vaughn
Frances L
FL
Doherty
Sally A
SA
Leaverton
Paul E
PE
Zhang
Weiya
W
Muir
Kenneth R
KR
Rampersaud
Evadnie
E
Dennison
Elaine M
EM
Edwards
Mark H
MH
Jameson
Karen A
KA
Javaid
M Kassim
MK
Spector
Tim D
TD
Cooper
Cyrus
C
Maciewicz
Rose A
RA
Doherty
Michael
M
D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D020918:Complex Regional Pain Syndromes / Q000175:diagnosis / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D016014:Linear Models; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009154:Mutation; D062556:NAV1.7 Voltage-Gated Sodium Channel; D016017:Odds Ratio; D020370:Osteoarthritis, Knee / Q000000981:diagnostic imaging / Q000235:genetics*; D010147:Pain Measurement; D010641:Phenotype; D011859:Radiography; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D015222:Sodium Channels / Q000235:genetics*; D006113:United Kingdom; D014481:United States
D062556:NAV1.7 Voltage-Gated Sodium Channel; C486866:SCN9A protein, human; D015222:Sodium Channels